Food and Drug Administration Drug Safety Podcast
FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:00
- Mais informações
Informações:
Sinopse
Listen to an audio podcast of the August 28, 2019 FDA Drug Safety Communication: FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi with advanced liver disease.
